[Oxidative metabolism of HIV-infected macrophages: the role of glutathione and a pharmacologic approach].
D000111:Acetylcysteine / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000633:toxicity; D019380:Anti-HIV Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D019328:Buthionine Sulfoximine / Q000494:pharmacology; D002478:Cells, Cultured; D003543:Cysteamine / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000633:toxicity; D004353:Drug Evaluation, Preclinical; D005978:Glutathione / Q000502:physiology*; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008264:Macrophages / Q000378:metabolism / Q000821:virology*; D018384:Oxidative Stress; D011355:Prodrugs / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis; D014779:Virus Replication / Q000187:drug effects
Métabolisme oxydatif dans les macrophages infectés par le VIH: rôle du glutathion et approche pharmacologique.